Search clinical trials for: rituximab injection

Total 12747 results

Andres J. M. Ferreri

Completed

Intralesional Rituximab for the Treatment of Conjunctival Indolent Lymphoma (IRIS)

Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma

Italy
Lixia Sheng

Not yet recruiting

Clinical Study of OR for Second-line Treatment of Refractory MZL

OR Regimen Refractory Marginal Zone Lymphoma
Beijing Friendship Hospital

Recruiting

Rituximab Monotherapy for EBV-HLH and CAEBV

Chronic Active Epstein-Barr Virus Infection | Secondary Hemophagocytic Lymphohistiocytosis

China
New York Medical College

Recruiting

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura (NYMC207)

Immune Thrombocytopenic Purpura

United States
Cogent Biosciences, Inc.

Terminated

Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma

Lymphoma

United States
Washington University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenic Purpura

United States
Cogent Biosciences, Inc.

Completed

Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma

Lymphoma

United States
Genentech, Inc.

Completed

A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)

Non-Hodgkin's Lymphoma
Genentech, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis (OLYMPUS)

Multiple Sclerosis
International Extranodal Lymphoma Study Group (IELSG)

Withdrawn

A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis

Lymphoma, B Cell
Ostfold Hospital Trust
Oslo University Hospital; South-Eastern Regional Health Authority

Completed

Rituximab as Second Line Treatment for ITP

Immune Thrombocytopenia (ITP)

Norway
Korea Cancer Center Hospital

Unknown

A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Relapsed or Refractory Diffuse Large B Cell Lymphoma

Korea, Republic of
The Cleveland Clinic
National Cancer Institute (NCI)

Completed

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Lymphoma

United States
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects

Severe Asthma

China
Northwestern University
Bristol-Myers Squibb; National Cancer Institute (NCI); AbbVie

Withdrawn

Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Richter Syndrome | Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma | Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma | Recurrent Transformed Chronic Lymphocytic Leukemia | Refractory Transformed Chronic Lymphocytic Leukemia

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Active, not recruiting

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent... and other conditions

United States
First Affiliated Hospital, Sun Yat-Sen University

Recruiting

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

Primary Membranous Nephropathy

China
McMaster University
HAMSMaRT; Keeping Six; YWCA Hamilton

Not yet recruiting

The Injection-Related InfectionS (IRIS) Program (IRIS)

Infections | Peer Support | Injection-related Infections | People Who Infect Drugs (PWID)

Canada
Immorna Biotherapeutics, Inc.

Recruiting

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Malignant Solid Tumor | Cutaneous Tumor

China
Mabwell (Shanghai) Bioscience Co., Ltd.

Completed

A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection

Asthma | Atopic Dermatitis | COPD

China
Mabwell (Shanghai) Bioscience Co., Ltd.
Huashan Hospital

Completed

A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection

Staphylococcus Aureus Infection

China
Gmax Biopharm Australia Pty Ltd.
Metaclinical; Syneos Heath

Completed

A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers

Pulmonary Arterial Hypertension

Australia
Mayo Clinic
Genentech, Inc.

Completed

Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis

Fibrillary Glomerulonephritis

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's Hospital

Completed

High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas

B-cell Lymphoma | Indolent B-cell Lymphoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Anemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Vivozon, Inc.

Completed

A Single Ascending Dose Escalation to Investigate Safety and PK of VVZ-149 Injection in Healthy Older Male Volunteers

Healthy
German High-Grade Non-Hodgkin's Lymphoma Study...
Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma (NHL)

Germany
Celltrion

Completed

Long-Term Efficacy and Safety of CT-P10 in Patients With RA

Rheumatoid Arthritis

Korea, Republic of
Celgene
The Lymphoma Academic Research Organisation

Active, not recruiting

Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma (RELEVANCE)

Follicular Lymphoma

United States, Japan
University College, London
Roche Pharma AG; Cancer Research UK

Completed

Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

Lymphoma

New Zealand, United Kingdom, Australia
East Carolina University
Genentech, Inc.

Completed

Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis (PAP)

Pulmonary Alveolar Proteinosis | Primary Disease

United States
Hoffmann-La Roche

Completed

A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Rheumatoid Arthritis

Israel
Hoffmann-La Roche

Completed

A Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

France
Hoffmann-La Roche

Completed

An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia

Lymphocytic Leukemia, Chronic

Sweden
Hoffmann-La Roche

Completed

A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Germany
Medical University of Vienna

Terminated

Rituximab in Metastatic Melanoma

Metastatic Melanoma

Austria
Beijing Tiantan Hospital

Not yet recruiting

Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis (SPECIALS)

Amyotrophic Lateral Sclerosis

China
Huashan Hospital

Not yet recruiting

Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)

Pompe Disease (Late-onset)

China
NYU Langone Health

Recruiting

UB-312 in Patients With Synucleinopathies

Parkinson Disease | Multiple System Atrophy

United States
Fujian Shengdi Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects

Type 2 Diabetes

China
Fujian Shengdi Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes

Overweight or Obesity

China
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion (CRAVE)

Central Retinal Vein Occlusion | Macular Edema

China
Beijing Zheng Ju Medical Technology Co., Ltd.

Unknown

The Randomized Controlled Clinical Trial of Kushen Injection

Lung Cancer

China
Zhejiang Kanglaite Pharmaceutical Co.Ltd
H & J CRO International, Inc.

Unknown

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

Cancer Cachexia

China
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline

Recruiting

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia (RITUX-PLUS 2)

Primary Immune Thrombocytopenia (ITP)

France
Vivozon, Inc.

Completed

Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection (P1_VVZ149IV)

Healthy

Korea, Republic of
Woman's Health University Hospital, Egypt

Unknown

Subcutaneous Sterile Water Injection for Relief of Low Back Pain

Low Back Pain
Royan Institute

Unknown

Transplantation of Autologous Cardiac Stem Cells in Ischemic Heart Failure

Heart Failure

Iran, Islamic Republic of
Hoffmann-La Roche

Completed

MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.

Non-Hodgkin's Lymphoma

Italy, Brazil, Slovenia, Spain, Germany, Switzerland, Russian Federation, Israel, Sweden, Albania, Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Colombia, Croatia, Ecuador, Egypt, Finland, Greece, Mexico, Romania, Slovakia, ...
University of California, Davis
Genentech, Inc.

Completed

Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States

Search clinical trials for: rituximab injection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations